The present invention provides for improved compositions comprising a PEGsTNF-R1 which, in addition to having useful higher concentrations, demonstrate decreased viscosity (<400 cP) and improved stability.

 
Web www.patentalert.com

< Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

< Thiadiazole compounds and methods of use

> Peptides and related molecules that bind to TALL-1

> Beta-secretase modulators and methods of use
~ 00600